SCHEMBL12443483

SCHEMBL12443483

O=[N+]([O-])c1ccc(Cl)c(/C=N/c2ccccc2O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.53
▸ MEN1 O00255 6/20 0.53
▸ KMT2A Q03164 6/20 0.53
▸ HTT P42858 4/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ XBP1 P17861 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ PKM P14618 1/20 0.51
▸ AMY1A P0DUB6 1/20 0.50
▸ FNTA P49354 1/20 0.50
▸ FNTB P49356 1/20 0.50
▸ TDP1 Q9NUW8 3/20 0.49
▸ KDM4E B2RXH2 1/20 0.48
▸ PSMD14 O00487 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ RECQL P46063 2/20 0.47
▸ CA12 O43570 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12443189 0.89 MAPT (0.63) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL9313016 0.85 CA12 (0.54) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL9313011 0.85 CA12 (0.54) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL17395842 0.85 MAPT (0.65) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL17395843 0.85 MAPT (0.65) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL10018561 0.83 MAPT (0.55) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL12485500 0.79 CA12 (0.60) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL13786955 0.79 CA12 (0.60) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL12443115 0.79 CDK2 (0.58) MAPTMEN1KMT2AHTTSMN1; SMN2
SCHEMBL6825490 0.79 CDK2 (0.58) MAPTMEN1KMT2AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785452-B2 Anti-infective compounds INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2014-07-22 — — US disclosed
US-20110178077-A1 Anti-infective compounds INSTITUT PASTEUR KOREA (KR) 2011-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178077-A1 Anti-infective compounds RABGGTB, ELANE, SERPINB1 MAPT 2660/4885MEN1 3685/4885KMT2A 4781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback